{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:20:31Z","timestamp":1772119231171,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00277-025-06234-z","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T22:12:36Z","timestamp":1742422356000},"page":"2563-2570","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Proinflammatory and prothrombotic conditions in JAK2V617F-positive MPN: a case of Lemierre\u2019s syndrome in essential thrombocythemia"],"prefix":"10.1007","volume":"104","author":[{"given":"Takuya","family":"Izumi-Tamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Takano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriaki","family":"Tachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiro","family":"Sone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Takada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiraku","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichiro","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihide","family":"Yoshimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiko","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,20]]},"reference":[{"issue":"3","key":"6234_CR1","doi-asserted-by":"publisher","first-page":"e379","DOI":"10.1055\/s-0039-3402433","volume":"24","author":"MR Gore","year":"2020","unstructured":"Gore MR (2020) Lemierre syndrome: a meta-analysis. Int Arch Otorhinolaryngol 24(3):e379\u2013e385. https:\/\/doi.org\/10.1055\/s-0039-3402433","journal-title":"Int Arch Otorhinolaryngol"},{"issue":"4","key":"6234_CR2","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jmii.2020.03.027","volume":"53","author":"WS Lee","year":"2020","unstructured":"Lee WS, Jean SS, Chen FL, Hsieh SM, Hsueh PR (2020) Lemierre\u2019s syndrome: a forgotten and re-emerging infection. J Microbiol Immunol Infect 53(4):513\u2013517. https:\/\/doi.org\/10.1016\/j.jmii.2020.03.027","journal-title":"J Microbiol Immunol Infect"},{"issue":"8","key":"6234_CR3","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1002\/lary.20542","volume":"119","author":"PD Karkos","year":"2009","unstructured":"Karkos PD, Asrani S, Karkos CD, Leong SC, Theochari EG, Alexopoulou TD, Assimakopoulos AD (2009) Lemierre\u2019s syndrome: a systematic review. Laryngoscope 119(8):1552\u20131559. https:\/\/doi.org\/10.1002\/lary.20542","journal-title":"Laryngoscope"},{"issue":"2","key":"6234_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.4103\/2231-0746.175746","volume":"5","author":"D Noy","year":"2015","unstructured":"Noy D, Rachmiel A, Levy-Faber D, Emodi O (2015) Lemierre\u2019s syndrome from odontogenic infection: review of the literature and case description. Ann Maxillofac Surg 5(2):219\u2013225. https:\/\/doi.org\/10.4103\/2231-0746.175746","journal-title":"Ann Maxillofac Surg"},{"issue":"8","key":"6234_CR5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.10131","volume":"12","author":"SP Dasari","year":"2020","unstructured":"Dasari SP, Gill H, Bodette H, Brandes E, Jha P (2020) A challenging case of lemierre\u2019s syndrome with central nervous system involvement and a comprehensive review. Cureus 12(8):e10131. https:\/\/doi.org\/10.7759\/cureus.10131","journal-title":"Cureus"},{"issue":"1","key":"6234_CR6","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1186\/s12883-024-03913-8","volume":"24","author":"J Song","year":"2024","unstructured":"Song J, Huang C, Jia L, Wang M, Wu C, Ji X, Song H, Meng R, Zhou D (2024) Cerebral venous sinus thrombosis associated with JAK2 V617F mutation-related pre-primary myelofibrosis: a case report and literature review. BMC Neurol 24(1):386. https:\/\/doi.org\/10.1186\/s12883-024-03913-8","journal-title":"BMC Neurol"},{"issue":"1","key":"6234_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.5582\/irdr.2021.01142","volume":"11","author":"M Giorelli","year":"2022","unstructured":"Giorelli M, Altomare S, Aniello MS, Leone R, Liuzzi D, Plasmati I, Sardaro M, Superbo M, Mennea G, Fioretto N, Guglielmi G, Balzano R, Scarabino T, Cuccorese G, Cialdella F, Campobasso G, Barbara M (2022) Lemierre\u2019s syndrome complicated by cerebral venous sinus thrombosis: a life threatening and rare disease successfully treated with empiric antimicrobial therapy and conservative approach. Intractable Rare Dis Res 11(1):37\u201339. https:\/\/doi.org\/10.5582\/irdr.2021.01142","journal-title":"Intractable Rare Dis Res"},{"issue":"4","key":"6234_CR8","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/ajh.27216","volume":"99","author":"A Tefferi","year":"2024","unstructured":"Tefferi A, Vannucchi AM, Barbui T (2024) Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management. Am J Hematol 99(4):697\u2013718. https:\/\/doi.org\/10.1002\/ajh.27216","journal-title":"Am J Hematol"},{"key":"6234_CR9","doi-asserted-by":"publisher","unstructured":"Rumi E, Pietra D, Ferretti V, Klampfl T, Harutyunyan AS, Milosevic JD, Them NC, Berg T, Elena C, Casetti IC, Milanesi C, Sant\u2019antonio E, Bellini M, Fugazza E, Renna MC, Boveri E, Astori C, Pascutto C, Kralovics R, Cazzola M, Italiana A, per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative I (2014) JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes. Blood 123(10):1544\u20131551. https:\/\/doi.org\/10.1182\/blood-2013-11-539098","DOI":"10.1182\/blood-2013-11-539098"},{"issue":"2","key":"6234_CR10","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/leu.2015.277","volume":"30","author":"D Pietra","year":"2016","unstructured":"Pietra D, Rumi E, Ferretti VV, Di Buduo CA, Milanesi C, Cavalloni C, Sant\u2019Antonio E, Abbonante V, Moccia F, Casetti IC, Bellini M, Renna MC, Roncoroni E, Fugazza E, Astori C, Boveri E, Rosti V, Barosi G, Balduini A, Cazzola M (2016) Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms. Leukemia 30(2):431\u2013438. https:\/\/doi.org\/10.1038\/leu.2015.277","journal-title":"Leukemia"},{"issue":"16","key":"6234_CR11","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1182\/blood-2014-05-579136","volume":"124","author":"A Tefferi","year":"2014","unstructured":"Tefferi A, Guglielmelli P, Larson DR, Finke C, Wassie EA, Pieri L, Gangat N, Fjerza R, Belachew AA, Lasho TL, Ketterling RP, Hanson CA, Rambaldi A, Finazzi G, Thiele J, Barbui T, Pardanani A, Vannucchi AM (2014) Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis. Blood 124(16):2507\u20132513. https:\/\/doi.org\/10.1182\/blood-2014-05-579136. (quiz 2615)","journal-title":"Blood"},{"issue":"20","key":"6234_CR12","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1182\/blood-2016-05-643346","volume":"128","author":"E Rumi","year":"2016","unstructured":"Rumi E, Cazzola M (2016) How I treat essential thrombocythemia. Blood 128(20):2403\u20132414. https:\/\/doi.org\/10.1182\/blood-2016-05-643346","journal-title":"Blood"},{"issue":"12","key":"6234_CR13","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1161\/STROKEAHA.112.671453","volume":"43","author":"JM Coutinho","year":"2012","unstructured":"Coutinho JM, Zuurbier SM, Aramideh M, Stam J (2012) The incidence of cerebral venous thrombosis: a cross-sectional study. Stroke 43(12):3375\u20133377. https:\/\/doi.org\/10.1161\/STROKEAHA.112.671453","journal-title":"Stroke"},{"issue":"10","key":"6234_CR14","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1161\/STROKEAHA.120.030800","volume":"51","author":"ES Kristoffersen","year":"2020","unstructured":"Kristoffersen ES, Harper CE, Vetvik KG, Zarnovicky S, Hansen JM, Faiz KW (2020) Incidence and mortality of cerebral venous thrombosis in a norwegian population. Stroke 51(10):3023\u20133029. https:\/\/doi.org\/10.1161\/STROKEAHA.120.030800","journal-title":"Stroke"},{"issue":"4","key":"6234_CR15","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1159\/000509802","volume":"83","author":"PS Idiculla","year":"2020","unstructured":"Idiculla PS, Gurala D, Palanisamy M, Vijayakumar R, Dhandapani S, Nagarajan E (2020) Cerebral venous thrombosis: a comprehensive review. Eur Neurol 83(4):369\u2013379. https:\/\/doi.org\/10.1159\/000509802","journal-title":"Eur Neurol"},{"issue":"1","key":"6234_CR16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1161\/STROKEAHA.122.039390","volume":"54","author":"LW Zhou","year":"2023","unstructured":"Zhou LW, Yu AYX, Ngo L, Hill MD, Field TS (2023) Incidence of cerebral venous thrombosis: a population-based study, systematic review, and meta-analysis. Stroke 54(1):169\u2013177. https:\/\/doi.org\/10.1161\/STROKEAHA.122.039390","journal-title":"Stroke"},{"key":"6234_CR17","doi-asserted-by":"publisher","unstructured":"Branchford BR, Carpenter SL (2018) The role of inflammation in venous thromboembolism. Front Pediatr 6. https:\/\/doi.org\/10.3389\/fped.2018.00142","DOI":"10.3389\/fped.2018.00142"},{"issue":"17","key":"6234_CR18","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1182\/blood-2013-09-526277","volume":"123","author":"S Antoniak","year":"2014","unstructured":"Antoniak S, Mackman N (2014) Multiple roles of the coagulation protease cascade during virus infection. Blood 123(17):2605\u20132613. https:\/\/doi.org\/10.1182\/blood-2013-09-526277","journal-title":"Blood"},{"issue":"3","key":"6234_CR19","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/rth2.12109","volume":"2","author":"S Antoniak","year":"2018","unstructured":"Antoniak S (2018) The coagulation system in host defense. Res Pract Thromb Haemost 2(3):549\u2013557. https:\/\/doi.org\/10.1002\/rth2.12109","journal-title":"Res Pract Thromb Haemost"},{"issue":"4","key":"6234_CR20","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1365-2141.2005.05753.x","volume":"131","author":"CT Esmon","year":"2005","unstructured":"Esmon CT (2005) The interactions between inflammation and coagulation. Br J Haematol 131(4):417\u2013430. https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05753.x","journal-title":"Br J Haematol"},{"issue":"10","key":"6234_CR21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s11926-018-0773-x","volume":"20","author":"C Mendoza-Pinto","year":"2018","unstructured":"Mendoza-Pinto C, Garcia-Carrasco M, Cervera R (2018) Role of infectious diseases in the antiphospholipid syndrome (Including Its Catastrophic Variant). Curr Rheumatol Rep 20(10):62. https:\/\/doi.org\/10.1007\/s11926-018-0773-x","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"6234_CR22","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/bjh.15821","volume":"185","author":"M Scully","year":"2019","unstructured":"Scully M, Levi M (2019) How we manage haemostasis during sepsis. Br J Haematol 185(2):209\u2013218. https:\/\/doi.org\/10.1111\/bjh.15821","journal-title":"Br J Haematol"},{"issue":"1","key":"6234_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5152\/UCD.2013.1852","volume":"30","author":"M Baykan","year":"2014","unstructured":"Baykan M, Gundogan K, Akyildiz HY, Yurci MA (2014) A rare cause of acute mesenteric ischemia: JAK2 positivity and chronic active hepatitis B. Ulus Cerrahi Derg 30(1):48\u201350. https:\/\/doi.org\/10.5152\/UCD.2013.1852","journal-title":"Ulus Cerrahi Derg"},{"key":"6234_CR24","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ejim.2024.01.023","volume":"122","author":"Y Yang","year":"2024","unstructured":"Yang Y, Ren Y, Zhang K, Chen M, Chen C (2024) Bone infarction: a rare complication of essential thrombocytosis with JAK2-V617F mutation. Eur J Intern Med 122:142\u2013143. https:\/\/doi.org\/10.1016\/j.ejim.2024.01.023","journal-title":"Eur J Intern Med"},{"issue":"12","key":"6234_CR25","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.1182\/bloodadvances.2023011692","volume":"8","author":"MC Bourrienne","year":"2024","unstructured":"Bourrienne MC, Le Cam DV, Faille D, Farkh C, Solo Nomenjanahary M, Gay J, Loyau S, Journe C, Dupont S, Ollivier V, Villeval JL, Plo I, Edmond V, Jandrot-Perrus M, Labrouche-Colomer S, Cassinat B, Verger E, Desilles JP, Ho-Tin-Noe B, Triquenot Bagan A, Mazighi M, Ajzenberg N (2024) Exacerbation of thromboinflammation by JAK2V617F mutation worsens the prognosis of cerebral venous sinus thrombosis. Blood Adv 8(12):3330\u20133343. https:\/\/doi.org\/10.1182\/bloodadvances.2023011692","journal-title":"Blood Adv"},{"issue":"10","key":"6234_CR26","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.1172\/JCI90312","volume":"128","author":"B Edelmann","year":"2018","unstructured":"Edelmann B, Gupta N, Schnoeder TM, Oelschlegel AM, Shahzad K, Goldschmidt J, Philipsen L, Weinert S, Ghosh A, Saalfeld FC, Nimmagadda SC, Muller P, Braun-Dullaeus R, Mohr J, Wolleschak D, Kliche S, Amthauer H, Heidel FH, Schraven B, Isermann B, Muller AJ, Fischer T (2018) JAK2-V617F promotes venous thrombosis through beta1\/beta2 integrin activation. J Clin Invest 128(10):4359\u20134371. https:\/\/doi.org\/10.1172\/JCI90312","journal-title":"J Clin Invest"},{"issue":"2","key":"6234_CR27","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41375-020-0909-7","volume":"35","author":"AR Landtblom","year":"2021","unstructured":"Landtblom AR, Andersson TM, Dickman PW, Smedby KE, Eloranta S, Batyrbekova N, Samuelsson J, Bjorkholm M, Hultcrantz M (2021) Risk of infections in patients with myeloproliferative neoplasms-a population-based cohort study of 8363 patients. Leukemia 35(2):476\u2013484. https:\/\/doi.org\/10.1038\/s41375-020-0909-7","journal-title":"Leukemia"},{"issue":"10","key":"6234_CR28","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1111\/jth.15834","volume":"20","author":"N Gangat","year":"2022","unstructured":"Gangat N, Singh A, Szuber N, Begna K, Elliott M, Wolanskyj-Spinner A, Hanson CA, Pardanani A, De Stefano V, Barbui T, Vannucchi AM, Tefferi A (2022) Site-specific venous thrombosis in essential thrombocythemia: Impact on subsequent vascular events and survival. J Thromb Haemost 20(10):2439\u20132443. https:\/\/doi.org\/10.1111\/jth.15834","journal-title":"J Thromb Haemost"},{"issue":"6","key":"6234_CR29","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1111\/j.1538-7836.2012.04719.x","volume":"10","author":"SM Passamonti","year":"2012","unstructured":"Passamonti SM, Biguzzi E, Cazzola M, Franchi F, Gianniello F, Bucciarelli P, Pietra D, Mannucci PM, Martinelli I (2012) The JAK2 V617F mutation in patients with cerebral venous thrombosis. J Thromb Haemost 10(6):998\u20131003. https:\/\/doi.org\/10.1111\/j.1538-7836.2012.04719.x","journal-title":"J Thromb Haemost"},{"issue":"11","key":"6234_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.94","volume":"5","author":"T Barbui","year":"2015","unstructured":"Barbui T, Vannucchi AM, Buxhofer-Ausch V, De Stefano V, Betti S, Rambaldi A, Rumi E, Ruggeri M, Rodeghiero F, Randi ML, Bertozzi I, Gisslinger H, Finazzi G, Carobbio A, Thiele J, Passamonti F, Falcone C, Tefferi A (2015) Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia. Blood Cancer J 5(11):e369. https:\/\/doi.org\/10.1038\/bcj.2015.94","journal-title":"Blood Cancer J"},{"issue":"3","key":"6234_CR31","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1200\/JCO.1990.8.3.556","volume":"8","author":"S Cortelazzo","year":"1990","unstructured":"Cortelazzo S, Viero P, Finazzi GA, D\u2019Emilio A, Rodeghiero F, Barbui T (1990) Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia. J Clin Oncol 8(3):556\u2013562","journal-title":"J Clin Oncol"},{"issue":"6","key":"6234_CR32","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/ejh.12759","volume":"97","author":"V Buxhofer-Ausch","year":"2016","unstructured":"Buxhofer-Ausch V, Steurer M, Sormann S, Schloegl E, Schimetta W, Gisslinger B, Ruckser R, Gastl G, Gisslinger H (2016) Influence of platelet and white blood cell counts on major thrombosis - analysis from a patient registry in essential thrombocythemia. Eur J Haematol 97(6):511\u2013516. https:\/\/doi.org\/10.1111\/ejh.12759","journal-title":"Eur J Haematol"},{"issue":"16","key":"6234_CR33","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1200\/JCO.2007.15.3569","volume":"26","author":"A Carobbio","year":"2008","unstructured":"Carobbio A, Antonioli E, Guglielmelli P, Vannucchi AM, Delaini F, Guerini V, Finazzi G, Rambaldi A, Barbui T (2008) Leukocytosis and risk stratification assessment in essential thrombocythemia. J Clin Oncol 26(16):2732\u20132736. https:\/\/doi.org\/10.1200\/JCO.2007.15.3569","journal-title":"J Clin Oncol"},{"issue":"7","key":"6234_CR34","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1182\/blood-2012-04-424911","volume":"120","author":"PJ Campbell","year":"2012","unstructured":"Campbell PJ, MacLean C, Beer PA, Buck G, Wheatley K, Kiladjian JJ, Forsyth C, Harrison CN, Green AR (2012) Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohort. Blood 120(7):1409\u20131411. https:\/\/doi.org\/10.1182\/blood-2012-04-424911","journal-title":"Blood"},{"issue":"2","key":"6234_CR35","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.thromres.2014.11.006","volume":"135","author":"M Borowczyk","year":"2015","unstructured":"Borowczyk M, Wojtaszewska M, Lewandowski K, Gil L, Lewandowska M, Lehmann-Kopydlowska A, Kroll-Balcerzak R, Balcerzak A, Iwola M, Michalak M, Komarnicki M (2015) The JAK2 V617F mutational status and allele burden may be related with the risk of venous thromboembolic events in patients with Philadelphia-negative myeloproliferative neoplasms. Thromb Res 135(2):272\u2013280. https:\/\/doi.org\/10.1016\/j.thromres.2014.11.006","journal-title":"Thromb Res"},{"issue":"8","key":"6234_CR36","doi-asserted-by":"publisher","first-page":"e43685","DOI":"10.7759\/cureus.43685","volume":"15","author":"A Tiwari","year":"2023","unstructured":"Tiwari A (2023) Lemierre\u2019s syndrome in the 21st century: a literature review. Cureus 15(8):e43685. https:\/\/doi.org\/10.7759\/cureus.43685","journal-title":"Cureus"},{"issue":"22","key":"6234_CR37","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","volume":"369","author":"RP Giugliano","year":"2013","unstructured":"Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Spinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM, Investigators EA-T (2013) Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 369(22):2093\u20132104. https:\/\/doi.org\/10.1056\/NEJMoa1310907","journal-title":"N Engl J Med"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06234-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06234-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06234-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T23:13:56Z","timestamp":1746400436000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06234-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,20]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["6234"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06234-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5416591\/v1","asserted-by":"object"}]},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,20]]},"assertion":[{"value":"8 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of the data and images in this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}